Option chain shows key data for Valhi's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Valhi.

Valhi (NYSE:VHI) Stock, Option Chain

Valhi

Valhi Inc is a holding company that provides chemicals, security products, waste management systems, and real estate development and management through its subsidiaries. It operates its business in three segments, which are Chemicals, Component Products, and Real Estate Management and Development. The company derives maximum revenue from the Chemicals segment. Chemicals Segment is a producer and marketer of value-added titanium dioxide pigments (TiO2). TiO2 is used to impart whiteness, brightness, opacity, and durability to a wide variety of products, including paints, plastics, paper, fibers, and ceramics. Geographically the company operates in the United States, Germany, Canada, Norway, and Belgium, where the majority of revenue comes from the United States.

Amazon, Crowdstrike, Autodesk, Dell, And Tesla: Why These 5 Stocks Are On Investors' Radars Today

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

ADSE

ANGO

ATXS

BASE

HEAR

JFIN

LMNR

PAHC

VINP

Limoneira And Other Big Stocks Moving Lower In Tuesday&#39;s Pre-Market Session

Intraday Update

ARQT

ASTS

BILI

BWLP

CAVA

LIND

LUMN

Nuveen Arizona Dividend Advantage Municipal Funds 3

POWL

ROKU

WDAY

CAVA Group Posts Strong Q2 Results, Joins Bilibili, Workday And Other Big Stocks Moving Higher On Friday

Long Ideas

Penny Stocks

Small Cap

AMRS

The most oversold stocks in the materials sector presents an opportunity to buy into undervalued companies.

Top 5 Materials Stocks That May Explode In May

Valhi Inc

VITALHUB CORP COM NO PAR by VITALHUB CORP

Vitalhub Corp

U.S. stock futures were mixed this morning, with the Dow futures falling around 0.1% on Tuesday.
Shares of Limoneira Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LMNR#NASDAQ">LMNR</a>) fell sharply in today's pre-market trading after reporting <a href="https://www.benzinga.com/quote/LMNR/news">fourth-quarter results.</a>
Limoneira posted an adjusted net loss of $1.6 million, or 9 cents per share, versus a year-ago loss of $2.6 million, or 15 cents per share. Its total net revenue rose to $43.9 million from $41.4 million in the year-ago quarter.
Limoneira shares fell 2.6% to $26.12 in the pre-market trading session.
Here are some other stocks moving lower in pre-market trading.
<ul>
<li>Tutor Perini Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TPC#NYSE">TPC</a>) dipped 12.1% to $22.01 in pre-market trading.</li>
<li>Astria Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATXS#NASDAQ">ATXS</a>) fell 11.8% to $8.40 in pre-market trading.</li>
<li>Jiayin Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JFIN#NASDAQ">JFIN</a>) shares fell 7.5% to $5.95 in pre-market trading. Jiayin Group, last week, announced the purchase of commercial property located in Shanghai, China for total cash consideration of RMB1.35 billion.</li>
<li>AngioDynamics, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANGO#NASDAQ">ANGO</a>) dipped 7.3% to $8.21 in pre-market trading. AngioDynamics will report financial results for the second quarter of fiscal year before the opening bell on Wednesday, Jan. 8, 2025.</li>
<li>Phibro Animal Health Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PAHC#NASDAQ">PAHC</a>) fell 5.2% to $20.51 in pre-market trading.</li>
<li>ADS-TEC Energy PLC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADSE#NASDAQ">ADSE</a>) shares fell 3% to $13.70 in pre-market trading.</li>
<li>Vinci Partners Investments Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VINP#NASDAQ">VINP</a>) fell 2.9% to $9.57 in pre-market trading.</li>
<li>Couchbase, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BASE#NASDAQ">BASE</a>) declined 2.4% to $14.91 in pre-market trading.</li>
<li>Turtle Beach Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HEAR#NASDAQ">HEAR</a>) declined 2.3% to $15.60 in pre-market trading.</li>
<li>Valhi, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VHI#NYSE">VHI</a>) fell 2% to $21.30 in pre-market trading.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/12/42648003/how-to-earn-500-a-month-from-qualcomm-stock-2">How To Earn $500 A Month From Qualcomm Stock</a></li>
</ul>

Limoneira And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

Earnings

ACXP

ADAP

AEMD

AFCG

AFYA

AGRO

AIRJ

ALUR

ALVO

ARCO

ATEX

AYTU

BCDA

BETR

BFRI

BITF

Bakkt Holdings, Inc. Class A Common Stock

BKKT

BNGO

BOXL

BRFS

BWEN

CAAS

CAPR

CREX

CRNT

CSAN

CSCO

CSLR

CSTE

CYBR

DADA

DGII

DMAC

DOLE

DRRX

DTCK

ECOR

EDBL

ENLT

EZPW

FORA

FPAY

FULC

GILT

GLAD

GOEV

GRYP

HIVE

HROW

HYZN

IBTA

ICAD

ICCC

INLX

INVZ

JAGX

JJSF

KBDC

KLIC

KMDA

KRMD

KULR

LMFA

LOAR

LQDA

LUCD

LVLU

MCRB

MPTI

MRSN

NTWK

NXGL

OMER

OPRX

OTRK

OWLT

OXBR

PAVM

PCYO

Earnings Scheduled For November 13, 2024

Valhi (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VHI#NYSE">VHI</a>) is preparing to release its quarterly earnings on Thursday, 2024-11-07. Here's a brief overview of what investors should keep in mind before the announcement.
Analysts expect Valhi to report an earnings per share (EPS) of $0.60.
Valhi bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Earnings Track Record</h3>
In the previous earnings release, the company beat EPS by $0.41, leading to a 12.36% increase in the share price the following trading session.
Here's a look at Valhi's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.60</td>
<td>0.29</td>
<td></td>
<td></td>
<td>0.01</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>2.01</td>
<td>0.70</td>
<td>0.27</td>
<td>0.14</td>
<td>-0.21</td>
</tr>
<tr>
<td>Price Change %</td>
<td>7.000000000000001%</td>
<td>12.0%</td>
<td>1.0%</td>
<td>7.000000000000001%</td>
<td>0.0%</td>
</tr>
</tbody>
</table>

<h3>Performance of Valhi Shares</h3>
Shares of Valhi were trading at $31.47 as of November 11. Over the last 52-week period, shares are up 120.93%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<h3>Analyst Views on Valhi</h3>
For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding Valhi.
With 1 analyst ratings, Valhi has a consensus rating of Underperform. The average one-year price target is $20.0, indicating a potential 36.45% downside.
<h3>Understanding Analyst Ratings Among Peers</h3>
The below comparison of the analyst ratings and average 1-year price targets of Ecovyst, Rayonier Adv Materials and Ginkgo Bioworks Holdings, three prominent players in the industry, gives insights for their relative performance expectations and market positioning.
<ul>
<li>Ecovyst is maintaining an Buy status according to analysts, with an average 1-year price target of $10.5, indicating a potential 66.63% downside.</li>
<li>The consensus outlook from analysts is an Outperform trajectory for Rayonier Adv Materials, with an average 1-year price target of $11.0, indicating a potential 65.05% downside.</li>
<li>As per analysts' assessments, Ginkgo Bioworks Holdings is favoring an Buy trajectory, with an average 1-year price target of $8.5, suggesting a potential 72.99% downside.</li>
</ul>
<h3>Peers Comparative Analysis Summary</h3>
In the peer analysis summary, key metrics for Ecovyst, Rayonier Adv Materials and Ginkgo Bioworks Holdings are highlighted, providing an understanding of their respective standings within the industry and offering insights into their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Valhi</td>
<td>Underperform</td>
<td>10.37%</td>
<td>$121.30M</td>
<td>2.10%</td>
</tr>
<tr>
<td>Ecovyst</td>
<td>Buy</td>
<td>3.37%</td>
<td>$54.70M</td>
<td>1.97%</td>
</tr>
<tr>
<td>Rayonier Adv Materials</td>
<td>Outperform</td>
<td>8.80%</td>
<td>$43.57M</td>
<td>-4.38%</td>
</tr>
<tr>
<td>Ginkgo Bioworks Holdings</td>
<td>Buy</td>
<td>-30.24%</td>
<td>$42.48M</td>
<td>-23.88%</td>
</tr>
</tbody>
</table>

Key Takeaway:
Valhi ranks at the top for Revenue Growth among its peers. It is in the middle for Gross Profit. Valhi is at the bottom for Return on Equity.
<h3>Unveiling the Story Behind Valhi</h3>
Valhi Inc is a holding company that provides chemicals, security products, waste management systems, and real estate development and management through its subsidiaries. It operates its business in three segments, which are Chemicals, Component Products, and Real Estate Management and Development. The company derives maximum revenue from the Chemicals segment. Chemicals Segment is a producer and marketer of value-added titanium dioxide pigments (TiO2). TiO2 is used to impart whiteness, brightness, opacity, and durability to a wide variety of products, including paints, plastics, paper, fibers, and ceramics. Geographically the company operates in the United States, Germany, Canada, Norway, and Belgium, where the majority of revenue comes from the United States.
<h3>Unraveling the Financial Story of Valhi</h3>
Market Capitalization Analysis: Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: Valhi displayed positive results in 3 months. As of 30 June, 2024, the company achieved a solid revenue growth rate of approximately 10.37%. This indicates a notable increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Materials sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 3.56%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): Valhi's ROE excels beyond industry benchmarks, reaching 2.1%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 0.78%, the company showcases effective utilization of assets.
Debt Management: With a below-average debt-to-equity ratio of 0.54, Valhi adopts a prudent financial strategy, indicating a balanced approach to debt management.
<a href="https://www.benzinga.com/quote/VHI/earnings">To track all earnings releases for Valhi visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Preview For Valhi

Valhi (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VHI#NYSE">VHI</a>) reported quarterly earnings of $2.01 per share. The company reported $533.600 million in sales this quarter. This is a 13.80 percent increase over sales of $468.900 million the same period last year.

Valhi Q3 2024 GAAP EPS $2.01, Sales $533.600M Up From $468.900M YoY

WIIM

Valhi shares are trading higher. Barclays raised its price target on the stock from $11 to $20.

Barclays analyst Michael Leithead maintains Valhi (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VHI#NYSE">VHI</a>) with a Underweight and raises the price target from $11 to $20.

Price Target

Analyst Ratings

Barclays Maintains Underweight on Valhi, Raises Price Target to $20

U.S. stocks were higher, with the Dow Jones index falling around 300 points on Friday.
Shares of CAVA Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAVA#NYSE">CAVA</a>) rose sharply during Friday&#8217;s session as the company reported better-than-expected <a href="https://www.benzinga.com/news/earnings/24/08/40527721/these-analysts-increase-their-forecasts-on-cava-group-after-strong-earnings">second-quarter financial results on Thursday.</a>
Cava Group reported quarterly earnings of 17 cents per share which beat the analyst consensus estimate of 12 cents by 41.67%. Quarterly sales clocked in at $233.495 million, beating the analyst consensus estimate by 7% and representing a 35.05% increase from the same period last year.
CAVA Group jumped 17% to $119.37 on Friday.
Here are some other big stocks recording gains in today's session.
<ul>
<li>Graphjet Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GTI#NASDAQ">GTI</a>) shares jumped 18.8% to $3.1016.</li>
<li>Arcutis Biotherapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARQT#NASDAQ">ARQT</a>) surged 18.3% to $9.84.</li>
<li>Lindblad Expeditions Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIND#NASDAQ">LIND</a>) gained 17.2% to $10.40.</li>
<li>Valhi, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VHI#NYSE">VHI</a>) gained 13.2% to $27.66.</li>
<li>Bilibili Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BILI#NASDAQ">BILI</a>) rose 12.5% to $14.57 after Barclays upgraded the stock from Equal-Weight to Overweight and raised its price target from $14 to $19.</li>
<li>Workday, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WDAY#NASDAQ">WDAY</a>) gained 10.6% to $255.66 as the company upbeat earnings for the second quarter.</li>
<li>NexGen Energy Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NXE#NYSE">NXE</a>) rose 10.1% to $6.39.</li>
<li>Roku, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROKU#NASDAQ">ROKU</a>) gained 9% to $67.35. Guggenheim analyst Michael Morris upgraded Roku from Neutral to Buy.</li>
<li>BW LPG Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BWLP#NYSE">BWLP</a>) rose 7.5% to $16.73.</li>
<li>Lumen Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LUMN#NYSE">LUMN</a>) climbed 7.3% to $6.48.</li>
<li>AST SpaceMobile, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASTS#NASDAQ">ASTS</a>) rose 6.4% to $36.37.</li>
<li>Powell Industries, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/POWL#NASDAQ">POWL</a>) gained 6% to $188.75.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/08/40527921/top-wall-street-forecasters-revamp-trip-com-group-price-expectations-ahead-of-q2-earnings">Top Wall Street Forecasters Revamp Trip.com Group Price Expectations Ahead Of Q2 Earnings</a></li>
</ul>

Valhi (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VHI#NYSE">VHI</a>) reported $507.10 million in sales this quarter. This is the same as the same period last year.

Valhi Q2 Sales $507.10M, Same YoY

Valhi (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VHI#NYSE">VHI</a>) reported quarterly earnings of $0.27 per share. This is a 258.82 percent increase over losses of $(0.17) per share from the same period last year. The company reported $530.60 million in sales this quarter. This is a 7.69 percent increase over sales of $492.70 million the same period last year.

Valhi Q1 EPS $0.27 Up From $(0.17) YoY, Sales $530.60M Up From $492.70M YoY

<h3>Companies Reporting Before The Bell</h3>
&bull; Creative Realities (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CREX#NASDAQ">CREX</a>) is expected to report quarterly earnings at $0.02 per share on revenue of $16.47 million.
&bull; InflaRx (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IFRX#NASDAQ">IFRX</a>) is projected to report quarterly loss at $0.20 per share on revenue of $1.42 million.
&bull; Fennec Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FENC#NASDAQ">FENC</a>) is likely to report quarterly loss at $0.02 per share on revenue of $8.67 million.
&bull; Welltower (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WELL#NYSE">WELL</a>) is likely to report quarterly earnings at $0.00 per share on revenue of $218.97 million.
&bull; VerifyMe (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRME#NASDAQ">VRME</a>) is expected to report quarterly loss at $0.03 per share on revenue of $8.95 million.
&bull; Academy Sports (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASO#NASDAQ">ASO</a>) is expected to report quarterly earnings at $2.29 per share on revenue of $1.79 billion.
&bull; Exscientia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXAI#NASDAQ">EXAI</a>) is expected to report quarterly loss at $0.35 per share on revenue of $17.05 million.
&bull; Direxion Daily CSI China Internet Index Bull 2X Shares (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CWEB#NYSE">CWEB</a>) is estimated to report quarterly loss at $0.09 per share on revenue of $32.93 million.
&bull; Winnebago Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WGO#NYSE">WGO</a>) is likely to report quarterly earnings at $0.88 per share on revenue of $720.40 million.
&bull; Commercial Metals (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMC#NYSE">CMC</a>) is projected to report quarterly earnings at $0.73 per share on revenue of $1.80 billion.
&bull; Titan Machinery (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TITN#NASDAQ">TITN</a>) is projected to report quarterly earnings at $1.02 per share on revenue of $724.20 million.
&bull; Designer Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DBI#NYSE">DBI</a>) is expected to report quarterly loss at $0.47 per share on revenue of $747.35 million.
&bull; Baozun (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BZUN#NASDAQ">BZUN</a>) is expected to report quarterly earnings at $0.16 per share on revenue of $382.28 million.
&bull; LiqTech Intl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIQT#NASDAQ">LIQT</a>) is likely to report quarterly loss at $0.24 per share on revenue of $5.40 million.
&bull; MediWound (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDWD#NASDAQ">MDWD</a>) is estimated to report quarterly loss at $0.23 per share on revenue of $5.32 million.
&bull; Yunji (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YJ#NASDAQ">YJ</a>) is projected to report earnings for its fourth quarter.
&bull; Innate Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IPHA#NASDAQ">IPHA</a>) is estimated to report earnings for its Fiscal Year 2023.
&bull; Mineralys Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MLYS#NASDAQ">MLYS</a>) is estimated to report earnings for its fourth quarter.
&bull; FactSet Research Systems (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FDS#NYSE">FDS</a>) is likely to report quarterly earnings at $3.88 per share on revenue of $546.75 million.
&bull; Darden Restaurants (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DRI#NYSE">DRI</a>) is expected to report quarterly earnings at $2.64 per share on revenue of $3.03 billion.
&bull; Accenture (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACN#NYSE">ACN</a>) is likely to report quarterly earnings at $2.66 per share on revenue of $15.83 billion.
&bull; X4 Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XFOR#NASDAQ">XFOR</a>) is expected to report earnings for its fourth quarter.
&bull; Lufax Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LU#NYSE">LU</a>) is likely to report quarterly loss at $0.02 per share on revenue of $1.05 billion.
&bull; Intuitive Machines (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LUNR#NASDAQ">LUNR</a>) is estimated to report quarterly loss at $0.36 per share on revenue of $22.20 million.
&bull; Allurion Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALUR#NYSE">ALUR</a>) is projected to report quarterly loss at $0.51 per share on revenue of $8.20 million.
&bull; Yiren Digital (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YRD#NYSE">YRD</a>) is likely to report earnings for its fourth quarter.
&bull; Kirkland&#39;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KIRK#NASDAQ">KIRK</a>) is expected to report quarterly earnings at $0.42 per share on revenue of $167.22 million.
&bull; Gambling.com Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GAMB#NASDAQ">GAMB</a>) is likely to report quarterly earnings at $0.19 per share on revenue of $27.69 million.
&bull; MiNK Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INKT#NASDAQ">INKT</a>) is likely to report earnings for its fourth quarter.
&bull; Nano Dimension (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NNDM#NASDAQ">NNDM</a>) is likely to report earnings for its fourth quarter.
&bull; Shoe Carnival (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCVL#NASDAQ">SCVL</a>) is likely to report quarterly earnings at $0.59 per share on revenue of $280.27 million.
&bull; Destination XL Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DXLG#NASDAQ">DXLG</a>) is projected to report quarterly earnings at $0.06 per share on revenue of $138.29 million.
&bull; CareCloud (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CCLD#NASDAQ">CCLD</a>) is estimated to report quarterly loss at $0.34 per share on revenue of $30.88 million.
&bull; Apyx Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APYX#NASDAQ">APYX</a>) is estimated to report quarterly loss at $0.18 per share on revenue of $14.85 million.
&bull; SNDL (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNDL#NASDAQ">SNDL</a>) is likely to report earnings for its fourth quarter.
&bull; 111 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YI#NASDAQ">YI</a>) is likely to report earnings for its fourth quarter.
&bull; Rockwell Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RMTI#NASDAQ">RMTI</a>) is projected to report quarterly loss at $0.07 per share on revenue of $22.63 million.
&bull; CENTRAL &amp; EASTERN EUROPE (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CEE#NYSE">CEE</a>) is expected to report earnings for its Fiscal Year 2023.
<h3>Companies Reporting After The Bell</h3>
&bull; Largo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LGO#NASDAQ">LGO</a>) is estimated to report quarterly loss at $0.05 per share on revenue of $47.10 million.
&bull; Xos (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XOS#NASDAQ">XOS</a>) is projected to report quarterly loss at $1.92 per share on revenue of $17.05 million.
&bull; Lululemon Athletica (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LULU#NASDAQ">LULU</a>) is projected to report quarterly earnings at $5.00 per share on revenue of $3.19 billion.
&bull; Cutera (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CUTR#NASDAQ">CUTR</a>) is estimated to report quarterly loss at $0.99 per share on revenue of $49.15 million.
&bull; Vitru (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VTRU#NASDAQ">VTRU</a>) is projected to report earnings for its fourth quarter.
&bull; Scholastic (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCHL#NASDAQ">SCHL</a>) is projected to report quarterly loss at $0.80 per share on revenue of $329.21 million.
&bull; Worthington Steel (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WS#NYSE">WS</a>) is estimated to report quarterly earnings at $0.84 per share on revenue of $700.50 million.
&bull; Journey Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DERM#NASDAQ">DERM</a>) is estimated to report quarterly loss at $0.08 per share on revenue of $15.06 million.
&bull; Asensus Surgical (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ASXC#AMEX">ASXC</a>) is likely to report quarterly loss at $0.08 per share on revenue of $5.30 million.
&bull; Valhi (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VHI#NYSE">VHI</a>) is expected to report quarterly earnings at $0.03 per share on revenue of $13.55 million.
&bull; Biolase (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIOL#NASDAQ">BIOL</a>) is projected to report quarterly loss at $2.55 per share on revenue of $13.55 million.
&bull; HireQuest (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HQI#NASDAQ">HQI</a>) is projected to report quarterly loss at $0.06 per share on revenue of $8.60 million.
&bull; Nike (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NKE#NYSE">NKE</a>) is likely to report quarterly earnings at $0.74 per share on revenue of $12.28 billion.
&bull; FedEx (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FDX#NYSE">FDX</a>) is likely to report quarterly earnings at $3.53 per share on revenue of $22.05 billion.
&bull; Intellicheck (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IDN#NASDAQ">IDN</a>) is expected to report quarterly earnings at $0.00 per share on revenue of $5.31 million.
&bull; Abacus Life (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABL#NASDAQ">ABL</a>) is estimated to report earnings for its fourth quarter.
&bull; AAR (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AIR#NYSE">AIR</a>) is estimated to report quarterly earnings at $0.84 per share on revenue of $567.63 million.
&bull; Amprius Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMPX#NYSE">AMPX</a>) is expected to report quarterly loss at $0.11 per share on revenue of $2.70 million.
&bull; CaliberCos (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CWD#NASDAQ">CWD</a>) is likely to report quarterly loss at $0.17 per share on revenue of $4.25 million.
&bull; Hyperfine (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HYPR#NASDAQ">HYPR</a>) is estimated to report quarterly loss at $0.18 per share on revenue of $3.71 million.
&bull; Cibus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CBUS#NASDAQ">CBUS</a>) is estimated to report quarterly loss at $1.43 per share on revenue of $380 thousand.
&bull; Direct Digital Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DRCT#NASDAQ">DRCT</a>) is likely to report quarterly earnings at $0.26 per share on revenue of $65.95 million.
&bull; TELA Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TELA#NASDAQ">TELA</a>) is expected to report quarterly loss at $0.43 per share on revenue of $16.39 million.
&bull; One Stop Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OSS#NASDAQ">OSS</a>) is projected to report quarterly loss at $0.04 per share on revenue of $13.01 million.
This article was generated by Benzinga&#39;s automated content engine and reviewed by an editor.

AMPX

APYX

ASXC

BIOL

BZUN

CBUS

CCLD

CUTR

CWEB

DERM

DRCT

DXLG

EXAI

FENC

GAMB

HYPR

IFRX

INKT

IPHA

KIRK

LIQT

LULU

LUNR

MDWD

MLYS

NNDM

RMTI

SCHL

SCVL

SNDL

TELA

TITN

VRME

VTRU

WELL

XFOR

Earnings Scheduled For March 21, 2024

Valhi (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VHI#NYSE">VHI</a>) reported quarterly earnings of $0.14 per share. This is a 142.42 percent increase over losses of $(0.33) per share from the same period last year. The company reported $453.00 million in sales this quarter. This is a 12.52 percent increase over sales of $402.60 million the same period last year.

Valhi Q4 EPS $0.14 Up From $(0.33) YoY, Sales $453.00M Up From $402.60M YoY

By the end of today, December 21, 2023, Valhi (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VHI#NYSE">VHI</a>) is set to deliver a dividend payout of $0.08 per share, equating to an annualized dividend yield of 2.90%. The company's dividend payout went ex-dividend on November 30, 2023, so only the investors that owned the stock prior to the ex-dividend date will receive this payout. 
<h3>Valhi Recent Dividend Payouts</h3>
<style>
 table {
 width: 100%;
 border-collapse: collapse;
 font-family: Arial, sans-serif;
 font-size: 14px;
 }

 th, td {
 padding: 8px;
 text-align: left;
 }

 th {
 background-color: #293a5a;
 color: #fff;
 text-align: left;
 }

 tr:nth-child(even) {
 background-color: #f2f4f8;
 }

 tr:hover {
 background-color: #e1e4ea;
 }

 td:nth-child(3), td:nth-child(5) {
 text-align: left;
 }

 .dividend-amount {
 font-weight: bold;
 color: #0d6efd;
 }

 .dividend-frequency {
 font-size: 12px;
 color: #6c757d;
 }
 </style><table>
<thead>
<tr>
<th>Ex-Date</th>
<th style="text-align: right;">Payments per year</th>
<th>Dividend</th>
<th>Yield</th>
<th>Announced</th>
<th>Record</th>
<th>Payable</th>
</tr>
</thead>
<tbody>
<tr>
<td>2023-11-30</td>
<td style="text-align: right;">4</td>
<td>$0.08</td>
<td>2.9%</td>
<td>2023-11-02</td>
<td>2023-12-01</td>
<td>2023-12-21</td>
</tr>
<tr>
<td>2023-08-31</td>
<td style="text-align: right;">4</td>
<td>$0.08</td>
<td>2.16%</td>
<td>2023-08-03</td>
<td>2023-09-01</td>
<td>2023-09-21</td>
</tr>
<tr>
<td>2023-06-02</td>
<td style="text-align: right;">4</td>
<td>$0.08</td>
<td>2.35%</td>
<td>2023-05-25</td>
<td>2023-06-05</td>
<td>2023-06-22</td>
</tr>
<tr>
<td>2023-03-10</td>
<td style="text-align: right;">4</td>
<td>$0.08</td>
<td>1.3%</td>
<td>2023-03-02</td>
<td>2023-03-13</td>
<td>2023-03-28</td>
</tr>
<tr>
<td>2022-11-30</td>
<td style="text-align: right;">4</td>
<td>$0.08</td>
<td>1.18%</td>
<td>2022-11-03</td>
<td>2022-12-01</td>
<td>2022-12-22</td>
</tr>
<tr>
<td>2022-08-31</td>
<td style="text-align: right;">4</td>
<td>$0.08</td>
<td>0.62%</td>
<td>2022-08-04</td>
<td>2022-09-01</td>
<td>2022-09-22</td>
</tr>
<tr>
<td>2022-06-03</td>
<td style="text-align: right;">4</td>
<td>$0.08</td>
<td>0.69%</td>
<td>2022-05-26</td>
<td>2022-06-06</td>
<td>2022-06-23</td>
</tr>
<tr>
<td>2022-03-11</td>
<td style="text-align: right;">4</td>
<td>$0.08</td>
<td>1.27%</td>
<td>2022-03-03</td>
<td>2022-03-14</td>
<td>2022-03-29</td>
</tr>
<tr>
<td>2021-12-01</td>
<td style="text-align: right;">4</td>
<td>$0.08</td>
<td>1.38%</td>
<td>2021-11-04</td>
<td>2021-12-02</td>
<td>2021-12-23</td>
</tr>
<tr>
<td>2021-09-01</td>
<td style="text-align: right;">4</td>
<td>$0.08</td>
<td>1.51%</td>
<td>2021-08-05</td>
<td>2021-09-02</td>
<td>2021-09-23</td>
</tr>
<tr>
<td>2021-06-04</td>
<td style="text-align: right;">4</td>
<td>$0.08</td>
<td>1.23%</td>
<td>2021-05-27</td>
<td>2021-06-07</td>
<td>2021-06-24</td>
</tr>
<tr>
<td>2021-03-12</td>
<td style="text-align: right;">4</td>
<td>$0.08</td>
<td>1.7%</td>
<td>2021-03-04</td>
<td>2021-03-15</td>
<td>2021-03-30</td>
</tr>
</tbody>
</table>
When it comes to dividend yield, Valhi stands tall above its industry peers, boasting a remarkable annualized dividend yield of 2.59%.
<h3>Analyzing Valhi Financial Health</h3>
Companies that pay out steady cash dividends are attractive to income-seeking investors, and companies that are financially healthy tend to maintain their dividend payout schedule. For this reason, investors can find it insightful to see if a company has been increasing or decreasing their dividend payout schedule and if their earnings are growing. 
<h3>YoY Growth in Dividend Per Share</h3>
<img src="https://www.benzinga.com/files/images/story/2023/1703171132_0.png" alt="dividend chart graph" />
Investors witnessed a decline in the company's dividend per share from $0.96 in 2019 to $0.32 in 2022. This downward trend in dividend payouts necessitates a comprehensive investigation to identify the reasons behind the decrease.
<h3>YoY Earnings Growth For Valhi</h3>
<img src="https://www.benzinga.com/files/images/story/2023/1703171132_1.png" alt="earning chart graph" />
From 2019 to 2022, Valhi has demonstrated an upward trend in earnings, with earnings per share rising from $2.16 to $5.32. This positive earnings growth bodes well for investors looking to generate income through cash dividend payouts.
<h3>Recap</h3>
In this article, we delve into Valhi's recent dividend payout and examine how it impacts shareholders. The company has announced a dividend distribution of $0.08 per share today, resulting in an annualized dividend yield of 2.90%.
When it comes to dividend yield, Valhi stands tall above its industry peers, boasting a remarkable annualized dividend yield of 2.59%.
With dividend per share decreasing and earnings per share increasing from 2019 to 2022, Valhi appears to be emphasizing business growth by reinvesting profits rather than focusing on dividend distributions.
Keeping a close watch on the company's performance in the coming quarters will enable investors to stay abreast of any modifications in financials or dividend disbursements.
[See current stock movements Valhi on Benzinga.](https://www.benzinga.com/quote/Valhi (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/vhi#NYSE">VHI</a>))
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Comments

Valhi

Valhi (VHI) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga